| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |